Commonwealth Equity Services, LLC Bio Cardia, Inc. Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$0.38 - $0.68 $1,520 - $2,720	4,000 Added 15.38%	30,000 $12,000
Q4 2023 Feb 06, 2024	BUY	$0.37 - $1.07 $5,885 - $17,021	15,908 Added 157.63%	26,000 $17,000
Q3 2023 Oct 23, 2023	SELL	$0.37 - $2.85 $17,717 - $136,475	-47,886 Reduced 82.59%	10,092 $4,000
Q2 2023 Aug 10, 2023	BUY	$1.52 - $2.8 $7,600 - $14,000	5,000 Added 9.44%	57,978 $155,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $30.3 $720 - $90,900	3,000 Added 6.0%	52,978 $102,000
Q1 2022 May 04, 2022	BUY	$21.3 - $39.0 $163,392 - $299,169	7,671 Added 18.13%	49,978 $103,000
Q4 2021 Jan 31, 2022	BUY	$25.65 - $46.05 $662,154 - $1.19 Million	25,815 Added 156.53%	42,307 $82,000
Q3 2021 Oct 29, 2021	BUY	$42.6 - $58.65 $702,559 - $967,255	16,492 New	16,492 $51,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $41.2M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.